
TSE:SIS
This summary was created by AI, based on 6 opinions in the last 12 months.
Savaria Corp (SIS-T) is experiencing a positive momentum due to its focus on the accessibility industry amidst a demographic trend of an aging population that prefers to age at home. Following challenges from tariffs that impacted its operations, the company has strategically shifted its production to the U.S. and is now compliant with CUSMA regulations, which helps in stabilizing its market position. Analysts note that a significant portion of its products is FDA-regulated, shielding them from tariff impacts. The company has shown resilience and growth potential, combined with cost-cutting measures and the introduction of new products. Its current yield of 2.69% and analysts' target price suggest prospects of further appreciation in stock value, making it an attractive long-term investment.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The Handicare acquisition is very big and will increase revenues by 50%. 5i likes the deal and believes there will be additional synergie over time. The deal is set to increase geographic reach and customer base. The financing may cause short term volatility but EBITDA was better than expected and sales were just below estimates. Unlock Premium - Try 5i Free